OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
16 sep 2008 - 00:28
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus announces the nomination of expanded Executive Board
Bericht
OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), the drug delivery and development company, announces today that the Board of Supervisory Directors will propose to expand the Executive Board with two new members at the next general meeting of shareholders later this year. The new Board will consist of Chief Executive Officer, Simon Sturge, Joost Holthuis, current CEO and founder, who will take up the new position of Chief Operating Officer, Chief Financial Officer Hans Pauli and Chief Business Officer Gerben Moolhuizen.
Expansion of the Executive Board to four people and the new division of responsibilities will ensure optimal use of expertise and experience to guide the Company to the next level and position OctoPlus for future growth and the building of shareholder value once the Company has secured a long term financing solution.
Datum laatste update: 21 februari 2026